{"url_path":"/sec/srtaw/8-k/2026-06-03/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1779128/0001628280-26-040342-index.html","accession_number":"0001628280-26-040342","cik":"0001779128","ticker":"SRTA","issuer_name":"Strata Critical Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1779128/0001628280-26-040342-index.html","primary_entity_key":"0001779128","primary_entity_name":"Strata Critical Medical, Inc."},"word_count":270,"has_tables":true,"body_markdown":"Item 5.07 - Submission of Matters to a Vote of Security Holders.\n\nOn May 28, 2026, Strata Critical Medical, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). The proposals are described in the Company’s definitive proxy statement for the Annual Meeting, as filed with the Securities and Exchange Commission on April 14, 2026. The final results for the votes regarding each proposal are set forth below.\n\n1.The Company’s stockholders elected the two (2) Class II directors listed below to the Board of Directors of the Company to hold office until the 2029 annual meeting of stockholders and until their respective successors have been duly elected and qualified. The votes regarding this proposal were as follows:\n\nFor\n\nWithhold\n\nBroker Non-Votes\n\nWilliam A. Heyburn\n\n46,050,902\n\n505,421\n\n12,687,496\n\nAndrew Lauck\n\n39,525,159\n\n7,031,164\n\n12,687,496\n\n2.The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The votes regarding this proposal were as follows:\n\nFor\n\nAgainst\n\nAbstain\n\n58,946,832\n\n65,815\n\n231,172\n\n3.The Company's stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers (the \"Say-on-Pay\" vote). The votes regarding this proposal were as follows:\n\nFor\n\nAgainst\n\nAbstain\n\nBroker Non-Votes\n\n38,497,962\n\n8,022,682\n\n35,679\n\n12,687,496\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nSTRATA CRITICAL MEDICAL, INC.\n\nDate: June 3, 2026\n\nBy:\n\n/s/ William A. Heyburn\n\nName:\n\nWilliam A. Heyburn\n\nTitle:\n\nCo-Chief Executive Officer and Chief Financial Officer"}